Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study - Etude épidémiologique sur les petits âges gestationnels
Journal Articles Early Human Development Year : 2023

Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study

Fichier principal
Vignette du fichier
1-s2.0-S0378378223001330-main.pdf (485.79 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive
licence

Dates and versions

hal-04239424 , version 1 (13-10-2023)

Licence

Identifiers

Cite

Sophie Breinig, Virginie Ehlinger, Jean‐christophe Rozé, Laurent Storme, Heloise Torchin, et al.. Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study. Early Human Development, 2023, 184, pp.105837. ⟨10.1016/j.earlhumdev.2023.105837⟩. ⟨hal-04239424⟩
149 View
35 Download

Altmetric

Share

More